BEQGX
Price
$40.39
Change
+$0.38 (+0.95%)
Updated
Sep 11 closing price
Net Assets
1.96B
VFINX
Price
$708.03
Change
+$6.07 (+0.86%)
Updated
Sep 11 closing price
Net Assets
1.76T
Interact to see
Advertisement

BEQGX vs VFINX

BEQGX vs VFINX Comparison Chart in %
View a ticker or compare two or three
VS
BEQGX vs. VFINX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEQGX is a StrongBuy and VFINX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.76T vs. BEQGX (1.96B). VFINX pays higher dividends than BEQGX: VFINX (0.94) vs BEQGX (0.44). BEQGX was incepted earlier than VFINX: BEQGX (35 years) vs VFINX (50 years). BEQGX (0.65) is less costly to investors than VFINX (0.14). BEQGX is a more actively managed with annual turnover of: 73.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than BEQGX: VFINX (0) vs BEQGX (2500). VFINX annual gain was more profitable for investors over the last year : 15.25 vs. BEQGX (9.29). VFINX return over 5 years is better than : 70.38 vs. BEQGX (10.58).
BEQGXVFINXBEQGX / VFINX
Total Expense Ratio0.650.14464%
Annual Report Gross Expense Ratio0.650.14464%
Fund Existence35 years50 years-
Gain YTD13.77211.097124%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.96B1.76T0%
Annual Yield % from dividends0.440.9447%
Returns for 1 year9.2915.2561%
Returns for 3 years64.2770.2492%
Returns for 5 years10.5870.3815%
Returns for 10 years58.35258.2823%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EVX39.940.34
+0.85%
VanEck Environmental Svcs ETF
XTN102.410.55
+0.54%
State Street® SPDR® S&PTrsptnETF
RCLR51.670.02
+0.04%
Reckoner BBB-B Clo Reinvesting ETF
CPNS28.33N/A
+0.01%
Calamos Nasdaq-100 Str Alt Prt ETF-Sep
IHE101.07-0.20
-0.20%
iShares US Pharmaceuticals ETF